Article
Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
BMC cancer - 9 Feb 2021
Sun Xuqi, Li Lingling, Xu Li, Zhou Zhongguo, Chen Jinbin, Wang Juncheng, Zhang Yaojun, Hu Dandan, Chen Minshan
Abstract excerpt
BACKGROUND: Patients with cancer history are usually excluded from hepatocellular carcinoma (HCC) clinical trials. However, whether previous malignancy affects the oncological outcomes of HCC patients has not been fully assessed. This study aimed to evaluate whether prior cancer compromised the survival of HCC patients. METHODS: Patients with HCC were extracted from the Surveillance, Epidemiology, and End Results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.